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Recognition of ubiquitin and polyubiquitin chains by
ubiquitin-binding domains (UBDs) is vital for ubiqui-
tin-mediated signaling pathways. The endoplasmic
reticulum resident RING finger ubiquitin ligase (E3)
gp78 regulates critical proteins via the ubiquitin-
proteasome system tomaintain cellular homeostasis
and includes a UBD known as the CUE domain,
which is essential for function. A probable role of
this domain is to recognize ubiquitin-modified sub-
strates, enabling gp78 to assemble polyubiquitin
chains on these substrates andmark them for degra-
dation. Here, we report the molecular details of the
interaction of gp78CUE domain with ubiquitin and
diubiquitin. The gp78CUE domain exhibits a well-
defined set of interactions with ubiquitin and a
dynamic, promiscuous interaction with diubiquitin
chains. This leads to a model in which the CUE
domain functions to both facilitate substrate binding
and enable switching between adjacent ubiquitin
molecules of a growing chain to enable processivity
in ubiquitination.
INTRODUCTION
The covalent attachment of ubiquitin (Ub) to cellular proteins,
most often to primary amines (ε-amino groups of Lys and to
the N termini of proteins) targets proteins for proteasomal
degradation and also plays critical roles in mediating a variety
of nonproteasomal functions (Komander and Rape, 2012). This
posttranslational modification is the result of a multistep pro-
cess involving three classes of proteins, known as ubiquitin-
activating enzymes (E1), ubiquitin-conjugating enzymes (E2s),
and substrate-specific ubiquitin protein ligases (E3) (Komander
and Rape, 2012). Common to most ubiquitination is the sequen-
tial formation of high-energy thioester bonds between the active
site Cys of E1 and E2 and the C terminus of ubiquitin (E1Ub,
E2Ub). Thereafter, there is a divergence of mechanism. The
homologous to E6-AP carboxyl terminus (HECT) E3s form a2138 Structure 20, 2138–2150, December 5, 2012 ª2012 Elsevier Ltdthioester intermediate with ubiquitin (E3Ub) analogous to E1
and E2 before nucleophillic attack by E3-bound substrate. The
large majority of ubiquitin ligases are characterized by RING
fingers or the related PHD/LAP fingers and U-box domains.
These E3s bind both the E2Ub and substrates and mediate
the transfer of ubiquitin from one to the other. Substrates may
be ubiquitinated on a single or several lysines resulting in mono-
ubiquitination. However, critical to the combinatorial complexity
of signaling through ubiquitin is the capacity of lysines on
the substrate-conjugated ubiquitin to act as acceptors during
sequential rounds of ubiquitination, thereby assembling polyubi-
quitin chains on substrate. Depending on which of the seven
lysines of ubiquitin act as the acceptor, the ubiquitin chains will
have different types of linkages with diverse conformations and
create a range of molecular signals in the cell (Komander and
Rape, 2012). For example, K48-linked polyubiquitin chains
generally target proteins for proteasomal degradation (Thrower
et al., 2000), a function now known to be shared with K11-linked
chains, whereas K63-linked chains can regulate kinase activa-
tion, DNA repair, signal transduction, and endocytosis (Pass-
more and Barford, 2004; Chen and Sun, 2009).
A primary determinant of the outcome of ubiquitination is the
recognition of ubiquitin or specific ubiquitin chains by ubiquitin
binding domains. To date, about 20 types of UBDs have been
characterized, including ubiquitin-associated domains (UBAs)
and the related coupling of ubiquitin conjugation to ER degrada-
tion (CUE) domains (Hurley et al., 2006; Ikeda and Dikic, 2008;
Wu et al., 2010; Winget and Mayor, 2010), ubiquitin-interacting
motifs (UIMs), and zinc fingers (ZFs). Recent structural studies
indicate that these diverse classes of UBDs have distinct spec-
ificities and modes of interaction (Hurley et al., 2006; Wu et al.,
2010; Winget and Mayor, 2010). Even among UBA domains,
one subgroup can preferentially bind to Lys48-linked chains,
another can bind to Lys63-linked chains, and a third group binds
to both without any preference (Raasi et al., 2005). Moreover, the
diverse modes of interaction do not segregate with their func-
tional roles. For example, hHR23A shuttles K48-linked sub-
strates to the proteasome, and its UBA domain binds to a
closed and ‘‘sandwich-like’’ conformation of diubiquitin (Vara-
dan et al., 2005). Alternatively, the proteasome receptors (S5a
and Rpn13) recognize the same K48-linked substrates but binds
to an open conformation of diubiquitin (Husnjak et al., 2008;All rights reserved
Figure 1. Structure of gp78CUE Domain
(A) Domain structure of gp78.
(B) 15N-1H HSQC spectrum of isolated gp78CUE
domain at 298 K. About 95% of the backbone
(labeled) and side-chain atoms are assigned. Side-
chain amide resonances of glutamine and aspar-
agine residues are connected by lines.
(C) Ensemble of the 20 lowest energy gp78CUE
structures shown in two different orientations. The
three helices a1, a2, and a3 are marked. The two
conserved leucines (L482 and L494) and the MFP
sequence are shown in the gp78CUE domain.
See also Figure S8.
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Promiscuous Interactions of CUE with PolyubiquitinZhang et al., 2009). E2’s like Ubc1 and E2-25K assemble K48-
linked chains, but their UBA domains bind to K63-linked chains
with higher affinity (Raasi et al., 2005). This underscores the
need for further structural investigations of various UBD/
polyubiquitin interactions in order to gain an understanding of
their mechanism of action.
CUE domains were identified in a database search based on
similarity to a region of the yeast Cue1 protein, which is impli-
cated in yeast endoplasmic Reticulum-associated degradation
(ERAD) (Ponting, 2000). The mechanistic role of CUE domains
in ERAD remains unclear. The yeast protein Vps9 includes a
CUE domain and is implicated in the yeast endocytotic pathway.
An extensive study of ubiquitin recognition by Vps9 has sug-
gested that the CUE domain binds to the ubiquitin conjugated
to HECT E3 Rsp5 and promotes self-monoubiquitination of
Vps9 (Prag et al., 2003; Shih et al., 2003). The generality of this
mechanism to other HECT E3s or RING E3s is not known.
A prominent human protein containing a CUE domain is the
mammalian ERAD E3 gp78 (also known as the human tumorStructure 20, 2138–2150, December 5, 2012 ªautocrine motility factor receptor or
RNF45). This E3 has a variety of targets
implicated in diverse physiological and
pathophysiological processes, including
lipid metabolism, metastasis, cystic fibro-
sis, and neurodegeneration (Song et al.,
2005; Tsai et al., 2007; Morito et al.,
2008). gp78 has a complex domain struc-
ture that includes a polytopic N-terminal
transmembrane region and a C-terminal
cytosolic domain (gp78C, amino acids
[aa]:313–643), which contains a RING
finger domain, a specific binding site for
its cognate E2 (Ube2g2) known as the
G2BR, and a CUE domain that has the
capacity to bind ubiquitin (Figure 1A).
The G2BR and RING domains interact
with Ube2g2, and a recent study re-
vealed that G2BR allosterically enhances
E2:RING binding and consequently ubiq-
uitination (Das et al., 2009). The position
of the CUE domain (gp78CUE:453–504)
is approximately central to the region
between the RING and G2BR, where it
is separated from each of them by struc-
turally dynamic regions of 50 aa and
70 aa, respectively (R.D. and R.A.B., unpublished data). All
three of these regions within gp78C are required for the cellular
function of gp78, including its self-regulation. However, the func-
tional role(s) of the gp78CUE domain have remained enigmatic
(Chen et al., 2006).
Two recent studies have provided a clue to the function of
gp78CUE domain. In vitro, gp78 can ubiquitinate an otherwise
nonsubstrate protein fused to ubiquitin, presumably via the
gp78CUE/ubiquitin interaction (Morito et al., 2008; Das et al.,
2009). In vivo, gp78 can catalyze polyubiquitin chain formation
on the pathogenic CFTRD508 after initial ubiquitination by
another ERAD E3 RMA1/RNF5, with the gp78CUE domain being
critical for this polyubiquitination (Morito et al., 2008). These data
point to a model in which one E3 can initiate substrate ubiquiti-
nation, targeting it to gp78 through the latter’s CUE domain for
polyubiquitination. This mechanism of chain elongation, where
gp78 functions in an E4-like manner, is reminiscent of several
other examples in which one E2:E3 pair monoubiquitinates
the target protein and another pair subsequently assembles2012 Elsevier Ltd All rights reserved 2139
Table 1. Structural Statistics of gp78CUE Structure
gp78CUE
NOE restraints
Intraresidue (ji  jj = 0) 282
Sequential (ji  jj = 1) 171
Medium-range (ji  jj < 5) 634
Long-range (ji  jjR 5) 102
Dihedral angles (f, 4) 97
Rmsd
Bond angles 0.7
Bond lengths 0.007 A˚
Rmsd (A˚)a
All backbone 0.64 ± 0.17





Most favored region 94.0%
Allowed region 6.0%
Generously allowed region 0.0%
Disallowed region 0.0%
Analysis was performed on ordered residues: (453–500).gp78CUE.
aRmsd and PROCHECK analysis were performed on the ensemble of the
20 lowest energy structures.
bMolprobity analysis was performed on the lowest energy structure.
Structure
Promiscuous Interactions of CUE with Polyubiquitinpolyubiquitin chains (Ulrich and Jentsch, 2000; Christensen
et al., 2007; Rodrigo-Brenni and Morgan, 2007). These studies,
however, do not rule out the possibility of recruiting substrates
directly via other regions in the cytosolic or the transmembrane
region of gp78.
With each cycle of ubiquitination a new ubiquitin molecule is
added to the end of the growing polyubiquitin chain. For this
processivity to occur the spatial relationship of the last ubiquitin
in the chain to the catalytic center, the RING-bound E2Ub,
must be maintained. Hence, there must be mechanisms to repo-
sition the growing substrate-bound ubiquitin chain. In this report,
we present the structures of gp78CUE domain and its complex
with ubiquitin and examine the interaction between gp78CUE
and diubiquitin using the two conformationally and functionally
diverse ubiquitin chains: K48-linked diubiquitin (K48-Ub2) and
K63-linked diubiquitin (K63-Ub2). To our knowledge, these find-
ings provide the first detailed insight into the dynamic structural
conformations of a CUE domain intrinsic to an E3 interacting with
diubiquitin chains, andmechanistic clues for the recruitment and
processive elongation of ubiquitin chains on gp78 substrates.
RESULTS
gp78CUE Domain Forms a Compact Three-Helix Bundle
The gp78CUE domain (453–504) was expressed in Escherichia
coli, isolated, and purified (details are in the Experimental
Procedures). Chemical shifts of approximately 95% of the back-
bone and side chain 13C, 1H, and 15N atoms of the domain were
assigned by standard three-dimensional (3D) nuclear magnetic
resonance (NMR) experiments (Sattler et al., 1999) (Figure 1B).
The three-dimensional solution structure of gp78CUEwas calcu-
lated using 1,189 distance restraints determined from 13C- and
15N-edited NOESY-HSQC experiments (averaging >14medium-
or long-range restraints per residue) and 97 dihedral angle
restraints (Figure 1C, structural statistics in Table 1). The high-
resolution structure reveals a three-helix bundle comprising of
helices a1 (S455–M467), a2 (Y473–L482), and a3 (V486–E495).
A total of 64 explicit interhelical contacts between these three
helices hold them together in a compact manner. The structure
superposes well with another NMR structure of the CUE domain
in gp78 (452–502, Protein Data Bank [PDB] ID code: 2EJS, root-
mean-square deviation [rmsd] = 0.69).
gp78CUE Recognizes the L8-I44-V70 Hydrophobic
Patch on Ubiquitin
The interaction between gp78CUE domain and ubiquitin was
probed by isothermal titration calorimetry (ITC). gp78CUE
was titrated into ubiquitin, and the resulting exothermic curve
was fit to a ‘‘one set of sites’’ binding model, yielding a Kd of
12.8 (±0.7) mM (Figure 2A). A variety of NMR experiments were
then used to study the gp78CUE/ubiquitin interaction. First,
unlabeled ubiquitin was titrated into 15N-labeled gp78CUE and
observed by 1H, 15N-HSQC (Figure S1 available online). The
difference of chemical shifts between the free and the
ubiquitin-bound states of gp78CUE is plotted as the chemical
shift perturbation (CSP) in Figure 2B, which indicates the binding
interface of gp78CUE. Peaks of some gp78CUE residues like
M467, F468, Q470, E487, and L494 had significant shifts. These
peaks showed a signature of intermediate exchange, which is in2140 Structure 20, 2138–2150, December 5, 2012 ª2012 Elsevier Ltdagreement with the low Kd determined by ITC. The same NMR
titration was repeated from the ubiquitin side and plotted in
Figures 2C and S2. A fit of the peak positions against the
ligand:protein ratio provide the dissociation constant Kd = 13.6
(±12) mM by NMR (Table 2; Figure S3).
Contacts at the gp78CUE/ubiquitin interface were identified
by detecting intermolecular NOEs between isotopically 2H,
13C, 15N, ILV-labeled gp78CUE and unlabeled ubiquitin. In the
2H, 13C, 15N, ILV-gp78CUE, all the nonexchangeable protons
in gp78CUE domain were substituted with deuterium, except
for the methyls of isoleucine, leucine, and valine residues (ILV).
In addition, all the backbone and side-chain amides were found
to be protonated via exchange with water. A 13C/15N-filtered,
13C/15N-edited NOESY-HSQC (Zwahlen et al., 1997) (Figure 2D)
detected 42 intermolecular NOEs between gp78CUE and ubiq-
uitin. Using the data of CSP and intermolecular NOEs, a solution
structure of gp78CUE/ubiquitin was calculated using HADDOCK
(de Vries et al., 2007) (Figure 2E). All 200 structures after the final
step of calculation were found in a single cluster with an overall
rmsd of 0.7 A˚. The buried surface area at the interface is 1,326
(±60) A˚2. The structural statistics are provided in Table 3, and
the noncovalent contacts at the interface are depicted in Fig-
ure 3. The structure reveals that a1 and a3 helices of gp78CUE
recognize the L8-I44-V70 hydrophobic patch on the b sheet of
ubiquitin, which is known to be the hot spot of interaction
between ubiquitin and its cofactors (Winget and Mayor, 2010).
We have also verified the heterodimeric structure of gp78CUE/
ubiquitin complex using paramagnetic relaxation effects
(PREs). A 2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl methylAll rights reserved
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Promiscuous Interactions of CUE with Polyubiquitinmethanesulfonothioate (MTSL) molecule was tagged at C12 in
a T12C ubiquitin mutant. When the MTSL-ubiquitin binds to
gp78CUE, the chemical shifts of gp78CUE remain identical to
those of gp78CUE when it binds free ubiquitin, indicating that
the MTSL has not disrupted the interaction between the mole-
cules. However, some peaks in gp78CUE broaden because of
PRE effects as expected. The observed PREs correlate well
with predicted PREs from the HADDOCK-calculated structure
(Q-factor = 0.33, Figure 2F), thereby validating the fidelity of
the gp78CUE/ubiquitin structure.
gp78CUE Exhibits Similar Interactions with Both
Proximal and Distal Units of K48-Ub2
The interaction of K48-Ub2 with gp78CUE domain was studied
using ITC and NMR spectroscopy. In the ITC experiment,
gp78CUE was titrated into K48-Ub2, and the resulting ex-
othermic curve could be fit to yield the Kd of 12.4 (±0.7) mM (Fig-
ure 4A). The stoichiometry of the interaction was found to be
1.9, suggesting that, when gp78CUE is added in excess, two
gp78CUE molecules can bind to a single K48-Ub2 molecule.
CSP data from NMR studies indicated that the interface
of gp78CUE when bound to K48-Ub2 was similar to that of
gp78CUE when bound to ubiquitin (compare 2b with 4b). The
interactions of gp78CUE domain with proximal and distal ubiqui-
tin were studied individually by designing K48-Ub2 molecules,
where either the proximal or the distal units are 15N isotope
labeled. These molecules were then titrated individually with
unlabeled gp78CUE. The CSP data indicated that both the prox-
imal and the distal ubiquitin present the same L8-I44-V70
interface to gp78CUE domain (compare Figure 2Cwith Figure 4C
and Figure 4D). The Kd of gp78CUE was estimated to be 13.4
(±8.2) mM and 22.6 (±16.4) mM for distal and proximal units,
respectively (Figure S4).
To map the contacts between gp78CUE and K48-linked Ub2,
intermolecular NOEs between gp78CUE and K48-linked Ub2
were measured. The same 2H, 13C, 15N, ILV-gp78CUE as above
was used along with fully protonated diubiquitin (K48-Ub2),
where both distal and proximal ubiquitin molecules are proton-
ated. Intermolecular NOEs observed between gp78CUE and
K48-Ub2 were similar to those observed between gp78CUE
and ubiquitin (Figure S5). To detect explicit contacts from indi-
vidual ubiquitin molecules in K48-Ub2 and gp78CUE, two
different samples of K48-linked Ub2 were used: (1) proximal
was deuterated, but distal was protonated (2H-Proximal-K48-
Ub2), and (2) distal was deuterated, but proximal was protonated
(2H-Distal-K48-Ub2). Because the intermolecular NOESY exper-
iment detects NOEs between protons exclusively, the spectra of
the gp78CUE/2H-proximal-K48-Ub2 complex was blind to NOEs
between the proximal ubiquitin and gp78CUE but exclusively
detected NOEs between the distal ubiquitin and gp78CUE. The
inverse was true for gp78CUE/2H-Distal-K48-Ub2 spectra.
However, the intermolecular NOESY spectra from both samples
were largely identical (Figure 4E). The NOEs from distal and
proximal were also similar to the NOEs from fully protonated
K48-Ub2 (data not shown), which should be a mere addition of
the spectra from samples (1) and (2). In addition, these NOEs
were similar to that of gp78CUE/ubiquitin (compare Figure 2C
and Figure 4D) and identified the same interface between the
hydrophobic patch of ubiquitin and the helices a1 and a3 ofStructure 20, 2138–21gp78CUE. Although a2 did not participate at the major interface,
one exclusive NOE was observed between a2 of gp78CUE and
the proximal ubiquitin. This NOE was attributed to a contact
formed between T66 of proximal ubiquitin and L482 of a
gp78CUE molecule whose a1 and a3 were bound to the distal
ubiquitin (Figure S6). The intermolecular NOEs observed from
protonated K48-Ub2 and 2H-Distal-K48-Ub2 were normalized
against the intensity of the L482-T66 NOE and compared to yield
the ratio of distal- and proximal-bound population of gp78CUE.
The ratio was found to be distal:proximal 1.6:1 indicating
a slightly higher population of distal bound gp78CUE. It is inter-
esting to note that the ratio of Kds between gp78CUE and the
distal/proximal ubiquitin in K48-Ub2 is Kd
15N-proximal:Kd
15N-distal
1.6 (Table 2), which is consistent with the inference from
intermolecular NOE comparison. Overall, the similarity of NOEs
between gp78CUE and the two ubiquitin units of diubiquitin
indicates that the gp78CUE binds to each of them in an
identical mode.
Multiple Conformations of K48-Ub2 in the Presence
of gp78CUE
To assess the range of conformational dynamics of K48-Ub2 in
the presence of gp78CUE, we used HADDOCK to calculate
structures of (1) gp78CUE bound to the proximal ubiquitin in
K48-Ub2 (Figures 5A and 5B) and (2) gp78CUE bound to the
distal ubiquitin in K48-Ub2 (Figures 5C and 5D). The NMR
data used in these calculations include the CSP and intermolec-
ular NOEs observed between gp78CUE and distal/proximal
ubiquitin (Table S1). The pairwise rmsd between these structures
and the gp78CUE/Ub complex aremodest (rmsd% 1, Table S2),
indicating that interface is essentially equivalent when gp78CUE
binds to either proximal or distal ubiquitin. In these structures the
ubiquitin that is not bound to gp78CUE can experience a range
of conformations, which could be specified with the volume
that subsumes the entire ensemble of structures. This ensemble
volume is 42,000 A˚3 for the proximal ubiquitin when gp78CUE is
bound to the distal ubiquitin (Figure 5D). The ensemble volume of
the distal ubiquitin, when gp78CUE is bound to the proximal
ubiquitin, is 62,000 A˚3 (Figure 5B).
The ITC experiments between gp78CUE and K48-Ub2 indi-
cated that, when K48-Ub2 is saturated with excess gp78CUE,
the stoichiometry can be two. To verify the possibility of a 2:1
(gp78CUE:K48-Ub2) complex, size-exclusion chromatography
was carried out on gp78CUE/K48-Ub2 complexes formed in
the approximate ratio of 2:1 and 1:1 (Figure S7). The profile of
the complex at a 2:1 ratio had a peak at the size of 28 kDa,
indicating that two gp78CUE molecules were bound to one
K48-Ub2 molecule. In contrast, the complex formed in a ratio
of 1.3:1 peaked at the molecular size of 22 kDa, indicating that
at equivalent concentrations one gp78CUE molecule binds to
one K48-Ub2 molecule. To further study the structural implica-
tions of the 2:1 complex, we modeled the complex in which
two gp78CUE molecules are bound to K48-Ub2, one each to
the proximal and distal ubiquitin (Figures 5E and 5F). This
modeling was performed in HADDOCK by using the restraints
observed individually from the proximal and distal ubiquitins in
the 1:1 complex. No major AIR violations, clashes, or major
alterations in pairwise rmsd were observed in the structures
(Tables S1 and S2), indicating that K48-Ub2 can bind to two50, December 5, 2012 ª2012 Elsevier Ltd All rights reserved 2141
Figure 2. Interaction between gp78CUE and Ubiquitin
(A) ITC evaluation of the interaction between gp78CUE and ubiquitin (D77). The titration curve indicates an exothermic reactionwith the dissociation constant Kd =
12.8 (±0.7) mM, stoichiometry = 0.91:1, enthalpy DH = 14.3 (±0.1) kJ mol1 and entropy DS = 46.2 J K1 mol1T1.
(B and C) Amide CSP (Dd) mapping of the interaction at the saturation for gp78CUE and ubiquitin, respectively.
(D)Selected strips from the 13C-filtered, 13C-editedNOESYspectra depicting intermolecular NOEsbetween 13C-bondedprotonsofCUEdomain andubiquitin. 13C
and 1H assignment of CUE atoms are given on the right and left of the strips, respectively. The protons of ubiquitin that show NOEs to CUE are assigned in blue.
Structure
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Table 2. Dissociation Constants between gp78CUE and Mono/
Diubiquitin
Sample (Cell) Titrant (Syringe) Kd (mM) Method
Ubiquitin gp78CUE 12.8 (±0.7) ITC
Ubiquitin gp78CUE 13.6 (±12.0) NMR
K48-Ub2 gp78CUE 12.7 (±0.7) ITC
K48-Ub2 (
15N-distal) gp78CUE 13.4 (±8.2) NMR
K48-Ub2 (
15N-proximal) gp78CUE 22.6 (±16.4) NMR
K63-Ub2 gp78CUE 14.5 (±1.0) ITC
K63-Ub2 (
15N-distal) gp78CUE 11.5 (±2.4) NMR
K63-Ub2 (
15N-proximal) gp78CUE 24.0 (±14.1) NMR
See also Figures S3 and S4.









Haddock score 82 (±12)
AIR viols 1.29 (±0.9)
Surface area 1,326 (±60)
Rmsd
Bond angles 0.6
Bond lengths 0.004 A˚
Rmsd (A˚)a
All backbone 0.50 ± 0.08
Structure
Promiscuous Interactions of CUE with Polyubiquitingp78CUE molecules simultaneously without any steric occlu-
sion. These structure calculations and the sizing measurements
suggest that K48-Ub2 can adopt multiple conformations in the
presence of gp78CUE, including open conformations.





Most favored region 91.4%
Allowed region 8.6%
Generously allowed region 0.0%
Disallowed region 0.0%
Analysis was performed on ordered residues: (1–74).ubiquitin and
(453–500).gp78CUE.
aRmsd and PROCHECK analysis were performed on the ensemble of the
20 highest scored structures found in a single cluster.
bMolprobity analysis was performed on the lowest energy structure.Interactions of gp78CUE with K48-Ub2 and K63-Ub2 Are
Similar
To compare the interaction of gp78CUE with K48-Ub2 and K63-
Ub2, the interaction of gp78CUEwith K63-Ub2was studied using
ITC and NMR. In an ITC study, gp78CUE was titrated into K63-
Ub2, and the resulting exothermic curve was fit to yield the Kd
of 14.5 (±1.0) mM (Figure 6A). CSP data from NMR studies indi-
cated that the interface of gp78CUE with K63-Ub2 was similar
to that with monoubiquitin and K48-Ub2 (compare Figure 6B
with Figures 2B and 4B). The interaction of the gp78CUE domain
with proximal and distal ubiquitin was studied individually by
designing K63-Ub2 molecules wherein either the proximal or
the distal units were 15N isotope labeled. These molecules
were then titrated individually with unlabeled gp78CUE. The
CSPdata indicated that both the proximal and the distal ubiquitin
presented the L8-I44-V70 interface to gp78CUE domain just as
monoubiquitin and K48-Ub2. The Kd of gp78CUE was estimated
to be 11.5 (±2.4) mM and 24 (±14.1) mM for distal and proximal
units, respectively. All of the above data indicates that gp78CUE
interacts in a similar fashion to both K48-Ub2 and K63-Ub2.DISCUSSION
Our structural studies reveal gp78CUE to be a compact three-
helical bundle, comprised of helices a1, a2, and a3, which is
characteristic among CUE domains (Ponting, 2000; Kang et al.,
2003; Prag et al., 2003; Shih et al., 2003). A sequence compar-
ison of CUE domains across species reveals three highly
conserved regions: (1) a region in which a proline residue is
preceded by two hydrophobic residues, (2) a leucine residue in(E) Solution structure of the gp78CUE/ubiquitin complex. The twenty lowest ener
colored in light blue. The N-terminal, C-terminal, and various secondary structur
(F) The calculated (blue line) PREs and observed (black squares, errors: one stand
of MTSL tagged at T12C of ubiquitin in the gp78CUE/ubiquitin complex correlat
calculate the PREs and is shown as an inset. Five red spheres represent the
conformation is shown in blue.
See also Figures S1, S2 and, S5 and Tables S1 and S2.
Structure 20, 2138–21the middle of the domain, and (3) another leucine residue toward
the end of the domain (Ponting, 2000) (also in Figure S8). In
gp78CUE, the conserved proline residue P469 occurs in the
loop between a1 and a2 and stabilizes the turn to align a2 relative
to a1. Among the two preceding hydrophobic residues M467
and F468, residue F468 maintains several crucial intramolecular
contacts, especially with a3, and a F468A mutant disrupts the
fold of the protein (R.D., J.L., and R.A.B., unpublished data).
Additionally, F468 is at the binding interface in the gp78CUE/
ubiquitin complex and makes several intermolecular contacts
at this interface (Figure 3). The M467 side chain is solvent
exposed and a M467A mutant is folded (R.D., J.L., and R.A.B.,
unpublished data), indicating that this residue is not important
for the intrinsic fold of the protein but could be crucial for interac-
tion with cofactors. Indeed, the M467 side chain packs tightly
between the b1 and b4 strands of ubiquitin and forms severalgy structures are shown, where gp78CUE is colored in green, and ubiquitin is
al regions are marked for the two proteins.
ard deviation) PREs of gp78CUE domain amide protons from the nitroxide atom
e well (Q-factor = 0.33). The lowest energy structure of (E) was used to back-
conformational freedom of the spin label, and the MTSL side chain of one
50, December 5, 2012 ª2012 Elsevier Ltd All rights reserved 2143
Figure 3. Noncovalent Interactions at the
gp78CUE/Ubiquitin Interface
(A) A view of the contact interface of ubiquitin
colored in blue, and the critical residues are
marked in black. The CUE-interacting side chains
are shown in yellow and labeled in red. The a1 and
a3 helices of CUE are colored in green, whereas
the helix a2 is hidden for clarity.
(B) A view of the interface on gp78CUE is shown
in yellow, and residues are labeled in red. The
beta-sheet structure of ubiquitin is rendered
semitransparent, whereas the interacting side
chain is shown in pink and labeled in black.
(C) Contacts at the interface between gp78CUE
domain and ubiquitin. The salt-bridges are shown
as blue broken lines, and the other contacts are
shown black solid lines.
See also Table S1.
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Promiscuous Interactions of CUE with Polyubiquitincritical contacts at the interface of the gp78CUE/ubiquitin
complex (Figure 3). In a previous study, it was found that the
Kd between yeast CUE domains and ubiquitin varies from
20 mM (Vps9-CUE, which contains the MFP sequence) to
160 mM (Cue1-CUE domain, which contains an LAP sequence)
(Shih et al., 2003). In gp78CUE, the low Kd 13 mM, observed
between ubiquitin and gp78CUE, is consistent with the MFP
sequence and the role of M467 and F468. The two other highly
conserved leucine residues in CUE domains, L494 and L482,
play important roles in gp78CUE/ubiquitin recognition. Residue
L494 is exposed at the C-terminal end of a3, is not crucial for
the fold of gp78CUE domain as determined by a L494A mutant
(R.D., J.L., and R.A.B., unpublished data), and makes contact
with R42, V70, and Q49 of ubiquitin at the interface of the
complex. Residue L482 is exposed at the N-terminal end of a2
but does not participate in the gp78CUE/ubiquitin complex.
Instead, L482 forms a contact with the proximal ubiquitin of
K48-linked diubiquitin when the a1 and a3 helices interact with
the distal ubiquitin. These conserved residues either stabilize
the fold of gp78CUE or form critical contacts for recognition of
mono- or diubiquitin via the hydrophobic patch on the b sheet
structure of ubiquitin (Figure 3), indicating structural and binding
homology among the CUE family. The ubiquitin hydrophobic
patch includes the conserved residues L8, I44, and V70 and
has been identified as the hot spot of interaction between ubiq-
uitin and its binding partners (Winget and Mayor, 2010). In the
gp78CUE complex, L8 is docked in between the hydrophobic
residues M467 and V486 of gp78CUE. Residue I44 also forms
hydrophobic interactions with the conserved residues F468
and L494, and V70 is positioned central to the interface exhibit-
ing an extensive set of van der Waals contacts with gp78CUE. In
addition, we find several salt bridges formed between basic
residues in ubiquitin (R42, R72, and R74) and acidic residues
of gp78CUE (E466, D491, and E495). The large set of interac-2144 Structure 20, 2138–2150, December 5, 2012 ª2012 Elsevier Ltd All rights reservedtions between the molecules (Figure 3)
provides specificity to the gp78CUE/
ubiquitin complex and is consistent with
the binding affinity.
Although it is known that the gp78CUE
is essential for biological function (Tsaiet al., 2007), the mechanistic role is as yet unknown. A putative
role for the gp78CUE domain may be to recruit substrates that
already bear one or more ubiquitin moieties (or a ubiquitin-like
domain [UBL]). It has been shown previously that proteins can
be made into a substrate for ubiquitination by gp78 (the E3)
acting with Ube2g2 (the E2) if the target protein bears a ubiquitin
moiety, formed as a fusion (Tsai et al., 2007; Morito et al., 2008;
Das et al., 2009). We postulate that this is due to recruitment and
possible positioning of the fusion target by the gp78CUE
domain. Similarly, some substrates of gp78, for example, the
in vitro substrate Herp (Li et al., 2009), include an UBL that is
highly similar to ubiquitin in sequence and structure. The Herp
UBL presents residues equivalent to ubiquitin I44 and V70, as
well as R74, suggesting that the contacts observed in the
gp78CUE/ubiquitin structure are supportive of gp78 recruiting
UBL-containing substrates. Subsequent to the first rounds of
ubiquitination, the substrate is modified with monoubiquitin or
a chain of two or more ubiquitin moieties, and the gp78CUE
domain will presumably recruit the substrate by binding to the
mono- or polyubiquitin chain. It is of interest to consider how
gp78CUE interacts with polyubiquitin chains and successfully
positions the last ubiquitin of the chain for extension. We demon-
strated that neither the affinity nor the mode of interaction with
each ubiquitin moiety in K48-Ub2 differed significantly from
that determined for monoubiquitin (Table 2; Figure 4). NMR
experiments confirm that the gp78CUE uses the same a1–a3
interface for binding to the identical L8-I44-V70 interface in
both the proximal and distal ubiquitin molecules, which is also
synonymous to the interface of monoubiquitin (Figure 4). In
support of our findings, a previous study has found that, at the
resolution of GST-based pull-down assays, yeast CUE domains,
which interact with ubiquitin weakly also bind polyubiquitin
weakly, and the CUE domains which interacted with ubiquitin
strongly bind polyubiquitin equally strong (Shih et al., 2003).
Figure 4. Interaction between gp78CUE and K48-Ub2
(A) ITC evaluation of the interaction between gp78CUE and K48-Ub2. The titration curve indicates an exothermic reaction with the dissociation constant Kd = 12.4
(±0.7) mM, stoichiometry = 1.94:1, enthalpy DH = 12.8 (±0.09) kJ mol1 and entropy DS = 51.7 J K1 mol1T1.
(B–D) Amide CSP mapping of the interaction at saturation in the titration for gp78CUE, 15N-labeled proximal unit of K48-Ub2, and
15N-labeled distal unit of K48-
Ub2, respectively. The diubiquitin Ub2 is modeled as two circles connected with a line, and the
15N-labeled labeled unit is colored gray.
(E) Selected strips from the 13C-filtered, 13C-edited NOESY spectra depicting intermolecular NOESY between 13C-bonded protons of CUE domain to proximal
and distal unit of K48-Ub2. The diubiquitin Ub2 is modeled as two circles connected with a line. Here, the
2H-labeled labeled unit is colored gray and does not
contribute to the NOESY spectrum. The 13C and 1H assignment of CUE atoms are given on the right and left of the strips, respectively. The protons of the ubiquitin
(either proximal or distal) unit that showNOEs to CUE are assigned in blue. Identical NOEs fromCUE to distal and proximal units of ubiquitin are connected by red
broken lines. Diagonal peaks arising because of leaked magnetization are marked as a green X.
Structure
Promiscuous Interactions of CUE with PolyubiquitinThus, the gp78CUE domain appears to act as a general recruit-
ment partner for ubiquitin and UBL-containing or ubiquitin-
modified substrates. The distal ubiquitin consistently shows
a slightly higher affinity for gp78CUE (Kd
proximal/Kd
distal 1.6),
which results in a higher population of distal-bound gp78CUEStructure 20, 2138–21species. Because the distal ubiquitin acts as the acceptor in
the next round of ubiquitin transfer, this state may be most
favorable for gp78CUE-mediated positioning. The modest, and
chain-length-independent, affinity supports a broad recruitment
mechanism, and the tendency to shift equilibrium toward the50, December 5, 2012 ª2012 Elsevier Ltd All rights reserved 2145
Figure 5. Multiple Conformations of K48-
Ub2 in the Presence of gp78CUE
(A) Highest scored structure in a NMR data-driven
HADDOCK structure calculation of the complex
between gp78CUE and proximal ubiquitin in
K48-Ub2.
(B) The ensemble of 20 structures representing
the different clusters of structures obtained in the
calculation. The structures are superposed with
reference to proximal ubiquitin. A partially trans-
parent surface is drawn in white to indicate the
conformational space accessed by the flexible
distal ubiquitin. gp78CUE is colored dark green,
proximal ubiquitin is colored dark blue, and the
distal ubiquitin is colored light blue.
(C) Highest scored structure in a NMR-data-
based HADDOCK structure calculation of the
complex between gp78CUE and distal ubiquitin in
K48-Ub2.
(D) The ensemble of the 20 best-scored structures
is superposed with reference to distal ubiquitin. A
surface is drawn to indicate the conformational
space accessed by the proximal ubiquitin. The
gp78CUE molecule is colored light green. A
consistently observed unique interaction between
distal-bound gp78CUE and the proximal ubiquitin
(apart from the L482-T66) is a hydrogen bond
between the side chain of R484 (gp78CUE) and the
side chain of S65 or backbone of N60 (proximal
ubiquitin, not shown for clarity).
(E) The highest scored HADDOCK structure
between two gp78CUE molecules and K48-Ub2.
(F) The ensemble of the 20 best-scored structures
is superposed with reference to distal ubiquitin.
Partially transparent surfaces are drawn to indi-
cate the conformational space accessed by the
proximal ubiquitin and the gp78CUE molecule
bound to it. The critical residues L8, I44, and V70 of
ubiquitin are shown in yellow. The unique L482-
T66 contact is shown in white and marked by
a dashed line.
See also Figures S6 and S7.
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Promiscuous Interactions of CUE with Polyubiquitindistal-bound state supports a possible positioning mechanism
for the gp78CUE domain in the ubiquitination process.
It is known that gp78 assembles primarily K48-linked
polyubiquitin chains on its substrates (Li et al., 2007). However,
the data presented here shows that gp78CUE is a promiscuous
binding partner for ubiquitin chains, as it binds to both K48- and
K63-linked chains with similar affinities and interfaces (Table 2;
Figure 6). Hence, a role of gp78CUE in linkage-type regulation,
if any, arises more likely from a spatial context influenced largely
by the RING finger:E2Ub complex. Because gp78CUE can
equally recognize K63-modified substrates, there exists a possi-
bility that gp78 coordinates with other E3s to assemble K63 and
K48mixed polyubiquitin chains on a substrate. For example, two
kinase adaptors were found that require K63-linked chains
initially to initiate NF-kB signaling, whereas at later times K48-
linked polyubiquitin modification targets them for proteasomal
degradation (Newton et al., 2008). However, it is not yet known2146 Structure 20, 2138–2150, December 5, 2012 ª2012 Elsevier Ltd All rights reservedif extension by gp78/Ube2g2 occurs on
a K63-linked substrate to create such
a mixed chain.Recent studies have described free ubiquitin chains as
dynamic ensembles of multiple conformations (Hirano et al.,
2011; Datta et al., 2009; Lai et al., 2012). The conformation of
ubiquitin chains in the presence of cofactors, however, is varied
(Varadan et al., 2005; Zhang et al., 2008; Wu et al., 2010; Winget
and Mayor, 2010). Although K48-Ub2 forms a closed, single
conformation bound to the hHR23A-UBA domain (Varadan
et al., 2005), it has an open conformation bound to the ubiqui-
lin-UBA domain (Zhang et al., 2008). The NMR-driven structural
modeling presented here demonstrated that K48-Ub2 can have
multiple conformations in the presence of gp78CUE domain.
When gp78CUE is bound to the proximal ubiquitin, the distal
ubiquitin can adopt a variety of three-dimensional conformations
spanning a volume of 62,000 A˚3 (Figure 5B). When gp78CUE
binds the distal ubiquitin, the flexibility of proximal ubiquitin is
reduced to a volume of 42,000 A˚3 because of additional contact
with gp78CUE (Table S1), but it still exchanges among multiple
Figure 6. Interaction between gp78CUE and K63-Ub2
(A) ITC analysis of the binding between gp78CUE and K63-Ub2. The titration curve indicates an exothermic reaction with the dissociation constant Kd = 14.5
(±1) mM, stoichiometry = 2.02:1, enthalpyDH=13.4 (±0.16) kJmol1 and entropyDS = 47.9 J K1mol1T1. Amide CSPmapping of the interaction at saturation
in the titration for (B) gp78CUE, (C) 15N-labeled proximal unit of K63-Ub2, and (D)
15N-labeled distal unit of K63-Ub2. The diubiquitin Ub2 is modeled as two circles
connected with a line, and the 15N-labeled labeled unit is colored gray.
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Promiscuous Interactions of CUE with Polyubiquitinconformations, including open conformations that can bind
another cofactor (Figure 5D). In fact, our structure calculations,
ITC, and size-estimation experiments indicate that in excess
concentration of gp78CUE, both the proximal and distal ubiqui-
tins can simultaneously recruit a gp78CUE molecule each,
substantiating that the K48-Ub2 can adopt open conformations
in the presence of gp78CUE.
It is not clear whether the gp78CUE:Ub2 (2:1) complex
observed in vitro is relevant to the function of gp78. In the E3
Cbl-b, dimerization of a UBA domain was found to be critical
for binding polyubiquitin chains and activity (Peschard et al.,
2007). The gp78CUE:Ub2 (2:1) complex observed in vitro
suggests that a diubiquitin chain could further assist dimerization
of two gp78 molecules induced by close proximity. CUE
domains have to date been reported as monomers in solution,
and the isolated gp78CUE domain (453–504) did not form dimers
up to concentrations of 1mM.Moreover, the net affinity of the 2:1
complex is roughly equivalent to the 1:1 complex, indicating that
there is no apparent driving force by gp78CUE alone to form
a gp78 dimer. However, an oligomerization domain does exist
in gp78 at residues N-terminal (419–448) to the CUE domain,
which is supportive of a model in which multiple gp78 molecules
work with Ube2g2 in a coordinated fashion (Li et al., 2009). The
self-association of the oligomerization domain combined with
spatially proximate gp78CUE domains binding polyubiquitinStructure 20, 2138–21could act synergistically to localize multiple gp78 molecules in
the ER membrane. The contribution of such complexes to the
overall functional mechanism in ERAD is an area of further
research.
In conclusion, we have defined the structure of the gp78CUE
domain and its binding complexes with ubiquitin and K48-Ub2
and have demonstrated that there is no affinity preference for
mono- versus diubiquitin or K48-Ub2 versus K63-Ub2. It is known
that gp78CUE occurs in the middle of an unstructured and
dynamic part of gp78C between the RING and G2BR domains,
thus providing spatial flexibility for the gp78CUE domain relative
to Ube2g2. We have also shown that K48-linked and K63-linked
polyubiquitin chains have a flexible interaction with gp78CUE,
where chains can adopt multiple conformations in its presence.
These data lead to two important mechanistic postulations for
the role of gp78CUE. First, gp78CUE could recruit a ubiquitin
chain (or UBL domain) on the target substrate by binding to any
ubiquitin molecule on the chain. Second, the combined spatial
flexibility of gp78CUE and the conformational flexibility of the
polyubiquitin chain would allow gp78CUE to shuffle between
adjacent ubiquitin molecules and correctly position the last ubiq-
uitin of the chain for attack on the thioester-linked ubiquitin at the
active site of Ube2g2. Because gp78CUE has no preference for
K48-Ub2 versus K63-Ub2 in recruitment, the factors determining
the linkage formation with the conjugated ubiquitin at the active50, December 5, 2012 ª2012 Elsevier Ltd All rights reserved 2147
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Promiscuous Interactions of CUE with Polyubiquitinsite likely involve interactions with, or conformational restriction
by, other components of the entire gp78:Ube2g2Ub complex
and require further structural examination. Multiple E3s like
Cbls, Nedd4, Huwe1, Rad18, etc., include ubiquitin binding
regions, and their contribution in the polyubiquitination of
substrates is an exciting subject of future research.
EXPERIMENTAL PROCEDURES
gp78CUE Expression and Purification
The CUE (aa: 453–504) of gp78 was subcloned into pET3a vector between
Ndel and BamHi restriction sites from the template of full-length gp78 clone
(gp78FL/pGEX). gp78CUE/ PET3a gene construct was transformed to BL21
Star E. coli (Invitrogen, Carlsbad, CA, USA). Cells were grown at 37C to an
OD600nm of 0.8 in M9 medium, and protein expression was induced by
1.0 mM IPTG, followed by another 4 hr growth and lysis. After lysis the pellet
was dissolved in 4 M Urea in 50 mM Tris (pH 7.2). The supernatant was
refolded in 4 M Urea to 0 M Urea in 50 mM Tris (pH 7.2) and loaded on to
Q-Sepharose HP column (GE Healthcare, Waukesha, WI, USA), followed by
Superdex 75 (GE Healthcare) on AKTA-FPLC for purification. For 15N-labeled
gp78CUE, recombinant E. coli cells were grown in M9 media with 15NH4Cl as
the only nitrogen source. For expression of DCN-ILV (2H,13C,15N-1H (Iled1, Leu,
Val) gp78CUE, regular M9/deuterium media (1 l) containing 2 g/l 13C,2H-
glucose and 1 g/l 15N NH4Cl was supplemented with 100 mg/l 2-keto-3-
(methyl-d3)-butyric acid-1,2,3,4-13C4, 50 mg/l 2-Ketobutyric acid-
13C4, 3,
3-d2 (Isotech, Champaign, IL, USA). Cell growth and protein purification
were performed as unlabeled gp78CUE.
Expression, Purification of Ubiquitin Mutants, and Synthesis
of K48-Ub2 and K63-Ub2
Plasmids of wild-type ubiquitin, K48A-, D77-, and D77/T12C-ubiquitins
(encoded by pET/pRSET-based plasmids) were transformed into BL21 Star
E. coli, respectively. Expression and purification of the above Ub mutants
were as described (Haldeman et al., 1997). For 15N-labeled Ub mutants,
E. coli cells were grown in M9 media with 15NH4Cl as the only nitrogen source.
Deuterated Ub mutants were expressed in deuterated M9 medium, using
2H,12C-glucose and D2O. K48-Ub2 and K63-Ub2 were synthesized as previ-
ously described (Piotrowski et al., 1997; Hofmann and Pickart, 2001).
ITC and SEC Studies
The binding affinity and stoichiometry of CUE with monoUb and Ub2 was
determined using iTC200 (MicroCal, Northampton,MA,USA) at 25
C. gp78CUE
and ubiquitin were dialyazed together against the same 50 mM Tris buffer
(pH 7.2), 100 mM NaCl. Nineteen aliquots of a 2.6 mM gp78CUE in syringe
(ligand) were injected into a 0.27 mM UbD77 (cell) stirred at 1,000 rpm, 25C.
The integrated interaction heat values were normalized as a function of
ligand concentration, and the data were fit using MicroCal Origin software.
The same procedure was performed on gp78CUE interacting with K48-Ub2
or K63-Ub2. For SEC experiments, samples were injected directly into the
sample loop and onto an analytical Superdex 75 (10/300, GE Healthcare)
column at a flow rate of 0.5 ml/minute in the 50 mM Tris, 150 mM NaCl
(pH 7.2) buffer. The protein peaks were detected by an UV monitor at a wave-
length of 280 nm.
Site-Directed Spin Labeling of MonoUb and PRE 1H-T2
Measurements
Residue T12 of Ub(D77) was mutated to a cysteine in order to enable covalent
tagging with a paramagnetic spin label, methanethiosulfonate (MTSL, Toronto
Research Chemicals, North York, Ontario, Canada). Lyophilized Ub(D77/
T12C) was dissolved in 50 mM Tris buffer (pH7.2) with 0.2 mM DTT, followed
by addition of MTSL (20X) and incubation for 3 hr. Dialysis of the protein
against 50 mM Tris (pH 7.2) eliminated excess MTSL. The extent of tagging
was confirmed to be 100% based on mass spectrometry. The concentration
of MTSL-tagged Ub(D77/T12C) was determined by Bradford protein assay.
gp78CUE was mixed with MTSL-tagged Ub(D77/T12C) at 1:1.5, and the final
concentration of MTSL-tagged Ub(D77/T12C) was 0.368 mM. The reduced
form of MTSL-tagged protein was obtained by addition of 10-fold excess of2148 Structure 20, 2138–2150, December 5, 2012 ª2012 Elsevier Ltdascorbic acid. The sample’s pH was adjusted back to 7.2 using 1 M Trizma
(Sigma-Aldrich, St. Louis, MO, USA). The PRE 1H-T2 effect was measured
and calculated as described previously (Iwahara et al., 2004). Recognizing
the conformational flexibility of the MTSL tag, 1HN-G2 rates were back-
calculated in Xplor-NIH using a five-conformer ensemble for the spin-label,
together with the Solomon-Bloembergen Model Free (SBMF) representation,
optimizing the coordinate positions in torsion angle space by simulated
annealing to minimize the difference between observed and calculated
1HN-G2 PRE rates, as described previously (Iwahara et al., 2004).
NMR Spectroscopy
NMR samples were prepared in 50 mM Tris (pH 7.0) and 50 mM NaCl, and all
experiments were performed at 25C. NMR spectra were acquired on 500,
600, and 800 MHz Varian INOVA spectrometers, or 600 and 700 MHz Bruker
Avance spectrometers equipped with triple-resonance gradient cryoprobes.
All NMR data were processed with NMRPipe (Delaglio et al., 1995). The 1H,
15N, and 13C backbone and side-chain resonances were assigned using stan-
dard 3D triple-resonance NMR experiments (Sattler et al., 1999), and peaks
were analyzed by Sparky (T.D. Goddard and D.G Kneller, University of Califor-
nia, San Francisco, San Francisco, CA). Distance information were obtained
from3D 15N/13C-editedNOESY-HSQC (tm=100ms) (Sattler et al., 1999). Inter-
molecular distance restraints in the gp78CUE:ubiquitin (1 mM:1.2 mM)
complex and the gp78CUE:K48-Ub2 (0.8 mM:0.96 mM) complex were
determined via a 13C/15N-filtered, 13C/15N-edited NOESY experiment (tm =
150 ms) (Zwahlen et al., 1997). The experiments were repeated with smaller
mixing time (tm = 75 ms) and produced similar spectra with lower peak inten-
sities, ruling out artifacts due to spin-diffusion. These experiments were also
repeated with nondecoupling during t1-increments to rule out peaks that
appear because of leaked magnetization during the purging pulses.
Titration of Ub or Ub2 with CUE was monitored by two-dimensional (2D)
1H-15N HSQC spectra of 15N Ub(D777) or Ub2 with one unit
15N-labeled,
respectively. The 2D HSQC spectra of 1 mM 15N Ub(D77) were acquired with
an increased amount of unlabeled gp78CUE at the Ub/gp78CUE molar ratios
of 0, 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 2.0, and 3.0. The same procedure was
applied in the Ub2/gp78CUE titration. The chemical shifts (d
H and dN) observed
in ubiquitin, K48-Ub2 and K63-Ub2 upon CUE titration was extracted from the
spectra using NMRViewJ and calculated as Dd = ((dHsat  dHfree)2 + ((dNsat 
dNfree)/5)
2)1/2 (Johnson, 2004). The Kd of gp78CUE/monoubiquitin interaction
was determined with the equation for an one-binding-site mode in a Matlab
program (Varadan et al., 2005). To obtain the Kd between proximal/distal
Ub of K48-Ub2 and gp78CUE domain, the
15N-proximal/distal labeled
K48-Ub2 (0.2 mM) was titrated with gp78CUE up to a molar ratio of
4 (0.8 mM, final concentration). The same experiment for K63-Ub2 and
gp78CUE domain, the 15N-proximal/distal labeled K63-Ub2 (0.24 mM)
was titrated with gp78CUE up to a molar ratio of 4 (0.96 mM, final concentra-
tion). The Kd values of gp78CUE/K48-Ub2 and gp78CUE/K63-Ub2 were
determined using a Matlab macro written for two independent binding sites
(Varadan et al., 2005).
Structural restraints defining the position of the gp78CUE relative to the
ubiquitin were determined frommeasurements of chemical shift perturbations
(CSP) and intermolecular NOEs. Ambiguous interaction restraints (AIR) were
defined for amide protons of gp78CUE residues that have Dd larger than 0.2
ppm to amide protons of the ubiquitin residues with Dd larger than 0.1 ppm.
The solution structure was calculated in HADDOCK (Dominguez et al., 2003)
using the lowest energy NMR structure of gp78CUE (this work) and ubiquitin
(PDB ID code: 1D3Z). All AIR and intermolecular NOE-derived restraints
were used during the docking steps. The interface of gp78CUE and ubiquitin
were kept semiflexible during simulated annealing and the water refinement.
The C-terminal end of gp78CUE (aa: 500–504) and ubiquitin (aa: 74–76)
were kept flexible throughout the structure calculation. The structures of
gp78CUE with K48-Ub2 were calculated similarly, except a distance restraint
was imposed between the C-terminal end of distal ubiquitin and the K48 side
chain of proximal ubiquitin.
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